973. Pharmacokinetic/Pharmacodynamic Evaluation and Dose Optimization of Daptomycin in Pediatric Patients with Staphylococcus aureus Bacteremia

BACKGROUND: Optimal dosing of daptomycin (DAP) in pediatric patients has not been elucidated in clinical practice. This study was conducted to examine DAP exposures achieved with package label dosing (PLD) and identify dosing regimens necessary to optimize efficacy and mitigate toxicity in pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Olney, Katie B, Howard, Joel I, Burgess, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677369/
http://dx.doi.org/10.1093/ofid/ofad500.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677369/
http://dx.doi.org/10.1093/ofid/ofad500.028

Ejemplares similares